Show metadata Hide metadata

(19)

(11)

2 815 482

(13)

(51)

IPC

A61K31/496(2006-01-01)

A61K31/5377(2006-01-01)

A61P27/02(2006-01-01)

(21) (22)

Application

2020109987, 2018-08-13

(24)

Start date

2018-08-13

(22)

Actual filing date

2018-08-13

(45)

Published

2024-03-18

(72)

Inventor

Hopkins, JillTsuruda, PamChapman, ClaudeSweigard, HarryPoon, YanMarquess, DanielDavid, NathanielDananberg, JamieLaberge, Remi-Martin

(73)

Holder

Unity Biotechnology, Inc.Buck Institute For Research On Aging

TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS Russian patent published in 2024 - IPC A61K31/496 A61K31/5377 A61P27/02

Abstract RU 2815482 C2

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine, namely ophthalmology, and is intended to inhibit pathological angiogenesis in the eye of a subject in need of it. To inhibit pathological angiogenesis in the subject’s eye, a therapeutically effective dosage of a pharmaceutical composition containing the following compounds or their pharmaceutically acceptable salts is administered.

EFFECT: use of the invention provides effective suppression of pathogenic angiogenesis in the eye due to the selected dose profile and high specificity.

7 cl, 14 dwg, 1 tbl, 12 ex

Similar patents RU2815482C2

Title	Year	Author	Number
GENE TRANSITION MEDIATED BY LENTIVIRAL VECTOR AND METHOD FOR USING THE GENES	2001	Staut Dzh. Timoti Appukuttan Binoj	RU2288742C2
METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION	2009	Robinson Majkl R. Blanda Uehndi M. Kh'Jus Patrik M. Berke Dzhehjms A. Vitkap Skott M.	RU2521338C9
METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION	2009	Robinson Majkl R. Blanda Uendi M. Khyus Patrik M. Berke Dzhejms A. Vitkap Skott M.	RU2668371C2
METHODS AND COMPOSITIONS FOR DESTROYING AGING CELLS AND FOR TREATING DISEASES AND DISORDERS ASSOCIATED WITH AGING	2015	Laberge Remi-Martin Campisi Judith Davalos Albert Demaria Marco David Nathaniel Vasserot Alain Philippe Baker Darren J. Childs Bennett G. Kirkland James L. Tchkonia Tamar Van Deursen Jan M.A. Zhu Yi Elisseeff Jennifer Kim Chaekyu Jeon Okhee	RU2716256C2
COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY	2002	Sherris Dehvid Vud Mark	RU2354398C2
COMPOSITIONS AND WAYS OF INJECTIONS OF AGENTS BINDING TUBULIN, FOR TREATMENT OF EYE DISEASES	2004	Sherris Dehvid Vud Mark	RU2359693C2
NEUTRAL ENDOPEPTIDASE (NEP) AND SOLUBLE HUMAN ENDOPEPTIDASE (SHE) INHIBITORS FOR PREVENTION AND TREATMENT OF EYE DISEASES	2019	Turski Kristofer	RU2758771C1
NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT	2019	Olmiere, Celine Mercier, Fabrice	RU2806096C2
INHIBITORS OF HYSTONE DEACETYLASE FOR TREATMENT OF DEGENERATIVE EYE DISEASES	2003	Khellberg Peggi Eh.	RU2324483C2
OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITIONS FOR NEOANGIOGENIC EYE PATHOLOGIES	2009	Matstsone Marija Gratsija Papa Vinchentso Dzhuliano Franchesko Marrano Manuehla	RU2519739C2

RU 2 815 482 C2

Authors

Hopkins, Jill

Tsuruda, Pam

Chapman, Claude

Sweigard, Harry

Poon, Yan

Marquess, Daniel

David, Nathaniel

Dananberg, Jamie

Laberge, Remi-Martin

Dates

2024-03-18—Published

2018-08-13—Filed